Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.39 USD | -3.80% | +2.17% | +41.83% |
Mar. 19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
Mar. 15 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- MarketScreener Editorial Features